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Adolfo Flores and George R. BuchananAssessing clinical bleeding in patients with immune thrombocytopenia (ITP) and predicting0037-1963
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S26future risk of major hemorrhage has proven to be a complicated task given the heterogeneity in
bleeding manifestations. Although bleeding scales have been used for this purpose, they fail to
account for occult or subclinical hemorrhage. Little is known about the frequency and clinical
significance of occult hemorrhage in ITP and no formal investigations have been published on
the subject. However, determining the prevalence and incidence of occult hemorrhage may
shed light on our understanding of bleeding severity in both children and adults. This review
explores the potential clinical significance, sites and methods of testing of subclinical
microbleeding in ITP.
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emorrhage in immune thrombocytopenia
(ITP) is extremely variable with regard to
body site and clinical severity. Platelet
count has often been used as a surrogate marker to
define bleeding severity and to predict future risk of
hemorrhage in persons with ITP. Despite having a
low platelet count (o20,000/mL), the great majority
of children with ITP do not have major bleeding at
diagnosis or during the following 28 days.1,2 Yet it is
difficult if not impossible for even the most experi-
enced hematologist to predict which children with
severe thrombocytopenia will develop life-threatening
hemorrhage upon presentation or later in the course
of their disease.
Over the past 30 years, hematologists have relied
on bleeding scales not only to grade or quantify
bleeding that is already apparent but also to help
gauge whether a particular patient may be at risk of
impending life-threatening hemorrhage.2–5 However,
there are many limitations and imperfections in theblished by Elsevier Inc.
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use of broad, subjective categories to define and
grade hemorrhage. The characteristics of these
bleeding tools have been extensively reviewed in
work previously published by Koreth and Key.6 One
of the constraints of most bleeding scales is that they
only measure readily observable bleeding. Most
hemorrhage in patients with ITP is external and
easily appreciated on physical examination. On the
other hand, bleeding in some ITP patients may also
be ‘‘occult’’ or ‘‘silent’’ and not readily determined
by history and/or physical examination. Such hem-
orrhage, if it were felt to be important, would have
to be evaluated through laboratory tests and/or
imaging studies.THE POTENTIAL IMPORTANCE OF ASSESSING
OCCULT HEMORRHAGIC SITES
Occult hemorrhage can theoretically occur in any
internal organ in ITP patients with severe thrombo-
cytopenia. Although most hematologists will ask
their patients whether they have noticed gross blood
in the urine or stool, many do not routinely test for
the presence of microscopic bleeding in these sites.
This is largely because it is not felt to occur or to be
important. Moreover, most previous ITP guidelines
do not specify whether the use of laboratory assess-
ments to test for microscopic blood should be
employed as means to guide patient management.7,8
Unfortunately, little is actually known about the
frequency and clinical relevance of occult hemor-
rhage in ITP. No formal investigations exist in the
literature regarding how often occult hemorrhage
indeed occurs in ITP and whether or not it isology, Vol 50, No 1, Suppl 1, January 2013, pp S26–S30
Table 1. Test to Evalute Occult Hemorrhage
Bleeding Site
Potential
Method Test Detection Limitations
Gastrointestinal9 Guaiac Heme (peroxidase activity) Dietary interference (plant
peroxidases, red meat,
vitamin C)
Immunochemical Globin Only detects colonic bleeding
Urinary10 Urinalysis
(dipstick)
Erythrocyte peroxidase activity False positive results
(myoglobinuria, dehydration,
excercise)
Microscopy
(3 RBCs/hpf)
RBC visualization
Retinal11 Dilated retinal
exam
Visualization of retina, retinal blood
vessels and optic nerve head (disc)
Patient cooperation required,
time-consuming
Brain12 MRI Brain microbleeds (hemosiderin
deposits)
Possible sedation in younger
children, costly
Abbreviations: RBC, red blood cell; hpf, high-power field; MRI, magnetic resonance imaging.
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est in developing better methods of assessing clinical
bleeding in ITP, largely by implementing more
sensitive bleeding scales. Since measurement of
disease manifestations remains one of the most
important tools of physicians (especially in a com-
plex disease such as ITP), determining the preva-
lence and incidence of occult hemorrhage may shed
light on our understanding of bleeding severity in
both children and adults.
Four sites of occult hemorrhage deserve special
attention, ie, microscopic hematuria, fecal occult
blood, retinal hemorrhage, and silent (subclinical)
intracranial hemorrhage (ICH). Table 1 provides a
review of potential tests and imaging methods that
might be used to assess each of these sites of occult
hemorrhage, along with their potential
limitations.9–12CASE REPORTS IN THE LITERATURE
Occult bleeding in ITP is infrequently reported in
the literature. Retinopathy is a frequent finding in
persons with severe thrombocytopenia, especially
when they are anemic as well. Accordingly, retinal
hemorrhages have been reported largely in patients
with leukemia, aplastic anemia, or myelodysplastic
syndromes.13,14 It is noteworthy that very little has
been written about ocular complications in children
or adults with ITP except for a few single case
reports in the ophthalmology literature. While some
cases of asymptomatic vitreoretinal hemorrhage
have been reported in chronic ITP patients,15,16
sudden loss of visual acuity secondary to retinal
bleeding has also been reported as the first present-
ing clinical feature in ITP.17,18 Two case reports (one
adult and one pediatric) have described retinalhemorrhage at diagnosis or shortly thereafter in the
absence of previous trauma occurring prior to or
concurrently with ICH.19,20HEMATURIA AND OTHER BLEEDING
MANIFESTATIONS
In 2009, Psaila et al reported a study of intra-
cranial hemorrhage in children with ITP identified
from 1987 to 2000.21 Forty patients with ICH and 80
matched ITP control subjects without ICH were
evaluated. Bleeding manifestations from diagnosis
of ITP to occurrence of ICH were distinguished
and compared between the two study populations.
Hematuria (22.5%) and head trauma (33%) were
identified to be the most prominent features in
children with ICH, whereas none of the control
subjects were reported as having hematuria and only
one had previous head trauma. Of the nine children
(22.5%) with ICH and urinary tract bleeding, five had
macroscopic while three had microscopic hematu-
ria, and in one child the nature of the bleeding was
unspecified. Additionally, bleeding beyond petechiae
and ecchymoses, including wet purpura, epistaxis,
and gastrointestinal bleeding, were described to be
linked to ICH, but this finding was not statistically
significant. Although this study may be among the
largest primary case series of ICH in children with
ITP, it is not without limitations. While reporting
biases are certainly a consideration, perhaps the
most important limitation of this study is that the
number of patients in the control population who
had urinalyses performed to determine the presence
or absence of microscopic hematuria is unknown.
Therefore, while an association between hematuria
and ICH was suggested in this study, the limited data
Table 2. Bleeding Frequency in Large Prospective Pediatric ITP Cohorts
No. of Reported Cases (%)
Cohort Evaluated Children (N) Gastrointestinal Urine Intracranial
ICIS Registry I22 2031 0 (0) 0 (0) 2 (0.1)
Nordic Cohort23 501 1 (0.2) 1 (0.2) 0 (0)
ICIS Registry II1 863 8 (0.9) 2 (0.2) 1 (0.1)
PARC ITP Registry24 1784 52 (2.9) 44 (2.5) 10 (0.6)
Abbreviations: ICIS, Intercontinental Childhood ITP Study Group; PARC, Pediatric and Adult Registry on Chronic ITP.
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group makes this association less convincing.
Upon examining large pediatric ITP cohort studies
that reported gastrointestinal, urinary and intracranial
hemorrhages, it appears that there has been a marked
increase in bleeding prevalence in these sites during
the past ten years (Table 2).1,22–24 Unfortunately,
none of these studies specified whether the gastro-
intestinal and urinary bleeding events were occult
(ie, microscopic) or gross (visible to the patient and
clinician) in nature. Nevertheless, this apparent
increase in bleeding frequency, particularly in sites
where bleeding has historically been perceived as
being less common, raises several questions: (1) Are
children with ITP now experiencing more bleeding
in these sites than previously thought? (2) Does the
potential for prior underreporting of gastrointestinal
and urinary bleeding exist given that ICH has
received so much attention as the only clinically
relevant site of ‘‘internal’’ bleeding? (3) Is it possible
that some hematologists have been more recently
supplementing their findings on physical examina-
tion with laboratory tests and imaging in order to
screen for occult hemorrhage?THE POSSIBILITY OF MINUTE CEREBRAL
CAPILLARY HEMORRHAGES IN ITP
One important site of occult bleeding that merits
further discussion is silent intracranial hemorrhage.
Subclinical intracranial bleeding was first hypothe-
sized to occur in a 1971 report by Matoth and Zaizev,
who described children with chronic ITP as possibly
having ‘‘minute cerebral capillary bleeding.’’25 These
authors observed that there was a high incidence of
minimal cerebral dysfunction (MCD) in their chronic
ITP patients. This led to an investigation in which
the authors compared 20 children with chronic ITP
to two control groups each consisting of 19
subjects—one with rheumatic fever and the other a
combination of healthy children and children suffer-
ing from chronic abdominal pain of uncertain etiol-
ogy. Neurological and psychological examinations
were completed on all subjects, with electroence-
phalographic (EEG) tracings obtained for the chronicITP population. According to the study’s findings,
20% of chronic ITP patients were diagnosed with
MCD and 50% of them were reported to have mild
diffuse EEG changes thought at the time to be
consistent with MCD. Consequently, the authors
speculated that acquired organic brain lesions might
explain these findings, which were possibly the
result of multiple minute cerebral capillary hemor-
rhages. Although this report has several flaws in its
methodology, to our knowledge it is the first to
speculate that subclinical intracranial hemorrhages
might occur in ITP and have potential deleterious
consequences.BRAIN MICROBLEEDS AS FUTURE
PREDICTORS OF ICH
Subclinical intracranial hemorrhages, also known
as brain microbleeds, are currently being studied by
neurology and neuroimaging specialists in adults
with hypertension and previous stroke as prognostic
markers for risk of developing future brain hemor-
rhages.26–28 Brain microbleeds are a radiologic con-
struct visualized through magnetic resonance
imaging (MRI) that represent perivascular collec-
tions of hemosiderin-laden macrophages and are
considered to be silent lesions resulting from pre-
vious petechial hemorrhages. These lesions are small
(o5 mm in diameter) and are reported to occur in
5% of healthy adults.12 Because this field of study is
relatively young, to date no consensus has been
reached regarding a specific imaging protocol that
would allow for optimal identification.
Studies reporting an association of overt ICH in
patients with brain microbleeds are conflicting.
While some reports suggest that the presence of
microbleeds following stroke increases a patient’s
risk of developing future ICH,29 others have indi-
cated that the risk of ICH remains low.30 Some data
suggest that location, such as cortical microbleeds,
may better predict future risk of symptomatic ICH.31
Microbleeds and their prognostic value have yet to
be studied in children and/or in patients with
bleeding disorders. Nevertheless, future study of
microbleeds in selected patients with severe ITP
Occult hemorrhage in immune thrombocytopenia S29may uncover the sequelae of occult bleeding and
should be considered.CONCLUSION
Little is known about occult hemorrhage in ITP.
Characterizing sites and prevalence of occult hem-
orrhage may provide greater understanding of the
heterogeneity in bleeding propensity among ITP
patients and its relationship to serious hemorrhagic
events, such as intracranial hemorrhage. Brain imag-
ing has revolutionized our management approach to
patients with many conditions, and the same could
hold true for patients with severe bleeding disorders,
including ITP. Although such testing for occult
bleeding should not yet become part of standard
care, this subject certainly merits future study.REFERENCES
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